Who Owns Phreesia?
Phreesia is a public company, so its ownership is spread across shareholders, not a single parent. Founded in 2005 by Chaim Indig and Evan Grossman, it went public in July 2019. The core question is how much control still sits with founders and large investors.
Phreesia trades on the NYSE under PHR and has no disclosed controlling family or sponsor. For a deeper view of the business context, see Phreesia PESTEL Analysis.
Who Founded Phreesia?
Phreesia ownership is mostly in public hands because Phreesia is listed on the Nasdaq under PHR. The clearest insider link is co-founder and CEO Chaim Indig, while Phreesia shareholders are mainly institutions and other outside investors.
Who owns Phreesia today starts with its listing status. As a public company, no single private owner is shown as controlling the business outright.
Phreesia founder ownership is centered on Chaim Indig. His role as co-founder and CEO makes him the most visible insider tied to Phreesia leadership.
Phreesia institutional investors usually hold the largest economic block. That is typical for a U.S. listed software company with a broad float.
Phreesia ownership structure matters because it shapes voting power and board pressure. Public holders watch dilution, execution, and capital use closely.
Phreesia parent company is not publicly presented as a control layer over the stock. That supports the view that Phreesia is publicly traded and independent.
For Mission, Vision & Core Values of Phreesia, the key point is simple. Credibility comes from how management and the board handle the public market.
Phreesia company owner questions are best answered by the cap table, not by one name. In practice, Phreesia stock ownership is spread across public shareholders, with voting and market discipline shaped by Phreesia board of directors and Phreesia investor relations disclosures.
Phreesia does not appear to have a controlling parent or a dual-class setup that overrides the rest of the shareholder base. That means the answer to Who owns Phreesia is mostly the public market, with insiders and institutions influencing direction through votes and holdings.
- Chaim Indig is the visible insider.
- Public shareholders hold the float.
- Institutions usually hold the biggest block.
- Governance depends on quarterly results.
Phreesia SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Phreesia’s Ownership Changed Over Time?
Phreesia ownership shifted from a founder-led private startup to a publicly traded healthcare platform after its 2019 IPO on the NYSE under the symbol PHR. That move changed who controls the business, added SEC disclosure, and gave Phreesia shareholders more visibility into Phreesia stock ownership and governance.
| Ownership event | What changed | Why it mattered |
|---|---|---|
| Founding phase | Founder control and private capital | High insider conviction shaped product focus |
| 2019 IPO | Phreesia became public | Broader shareholder base and SEC reporting |
| Post-IPO years | Institutional ownership grew | More governance pressure and market scrutiny |
| 2025 public market phase | Equity incentives and trading liquidity expanded | Founder influence diluted as shares spread |
Who owns Phreesia now comes down to a public-company mix: Phreesia institutional investors, company insiders, and other public market holders. Does anyone own Phreesia outright? No, because the Phreesia ownership structure is dispersed, and the Phreesia company owner is not a single parent company but a listed issuer with reporting duties and a board of directors that answers to shareholders.
Phreesia shareholders shape the brand meaning as much as the product does. After the IPO, ownership became more visible, and that usually raises trust because investors can inspect filings, votes, and risk disclosures.
- Institutional holders dominate public float
- Insiders still signal execution discipline
- Board oversight sets governance tone
- Investor relations shapes market trust
Phreesia founder ownership mattered early because founder-led control usually keeps product decisions close to the original mission. Over time, stock issuance, stock-based pay, and new public investors reduced that concentration, which is common after an IPO and especially relevant in healthcare, where reliability and patient confidence affect brand value. For a related view of market positioning, see Marketing Strategy of Phreesia.
Phreesia PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Phreesia’s Board?
Phreesia’s board of directors combines executive leadership with independent oversight, so control is shared rather than concentrated. Chaim Indig remains central as founder and CEO, but Phreesia ownership does not show a parent company or a family controller.
| Governance area | Who matters most | Why it matters |
|---|---|---|
| Board seats | Independent directors and management | They shape strategy, risk, and capital use |
| Shareholder votes | Phreesia shareholders and institutional investors | They influence director elections and pay votes |
| Executive authority | Chaim Indig and the leadership team | They run daily decisions and execution |
In a standard one-share-one-vote setup, Phreesia stock ownership is more dispersed than in a dual-class company, so no single holder should be assumed to control the outcome. That means the Phreesia board of directors, large Phreesia institutional investors, and the Phreesia executive team all matter when asking who owns Phreesia company power in practice.
Phreesia company owner rights are spread across directors, executives, and shareholders. If you want the business side, see the related Competitors Landscape of Phreesia.
- Chaim Indig guides day-to-day strategy
- Independent directors add oversight
- Institutional investors shape votes
- No obvious parent company control
For Phreesia shareholders, the key question is not does anyone own Phreesia outright, but who can sway votes and policy. If the board stays majority independent, governance usually looks stronger, and that can support trust in Phreesia investor relations and the Phreesia stock symbol PHR on the NYSE.
Phreesia ownership structure appears closer to a widely held public company than to a controlled private firm. That makes Phreesia founder ownership important in influence terms, but not absolute in voting terms, which is why Phreesia major shareholders and Phreesia institutional investors can still affect director elections and say-on-pay outcomes.
Phreesia Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Phreesia’s Ownership Landscape?
Phreesia ownership still looks steady in 2025: it remains a public company with no controlling sponsor, and founder continuity still matters for trust. That mix supports the Phreesia company owner story, because control is shared across Phreesia shareholders, Phreesia institutional investors, and a board that answers to the market.
| Ownership point | Recent trend | Why it matters |
|---|---|---|
| Public listing | Is Phreesia publicly traded on NYSE under PHR | Creates disclosure and voting accountability |
| Founder link | Founder continuity still shapes Phreesia leadership | Supports brand trust in healthcare software |
| Control profile | No single owner controls Phreesia outright | Limits takeover risk and forced exit pressure |
| Capital structure | Stock compensation and dilution remain key issues | Affects Phreesia stock ownership and per share value |
For Who owns Phreesia company, the main point is simple: no one owns Phreesia outright. The Phreesia ownership structure is public and spread across Phreesia major shareholders, Phreesia institutional investors, and insiders, with the board of directors and investor relations process keeping the market informed. That setup can help credibility, but only if execution stays tight and dilution stays under control. Read the linked business model overview for context on how the platform makes money: Revenue Streams & Business Model of Phreesia
Who founded Phreesia still matters to buyers and investors. A founder tied to the business can signal long term focus and product discipline.
Phreesia investor relations and SEC reporting add pressure to perform. That can improve discipline, but it also raises the bar on every quarter.
The Phreesia board of directors helps keep management accountable. That matters when a healthcare software business must balance growth, compliance, and service quality.
Phreesia stock ownership has been shaped by public market dilution and stock compensation since the 2019 IPO. The key risk is not control change, but whether incentives stay aligned.
Phreesia Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What is Customer Demographics and Target Market of Phreesia Company?
- What is Sales and Marketing Strategy of Phreesia Company?
- What is Growth Strategy and Future Prospects of Phreesia Company?
- What is Brief History of Phreesia Company?
- How Does Phreesia Company Work?
- What is Competitive Landscape of Phreesia Company?
- What are Mission Vision & Core Values of Phreesia Company?
Frequently Asked Questions
Phreesia is owned by public shareholders because it is a listed company on the NYSE under PHR. Founded in 2005 and public since 2019, it has no disclosed parent company or controlling family. The biggest visible influence comes from the CEO, the board, and large institutional holders.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.